Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
101772735 | 10177273 | 5 | F | 20150120 | 20160823 | 20140516 | 20160829 | EXP | US-GLAXOSMITHKLINE-A1073490A | GLAXOSMITHKLINE | 74.63 | YR | F | Y | 0.00000 | 20160829 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
101772735 | 10177273 | 1 | PS | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Unknown | UNK, U | 4ZP6846 | 21077 | INHALATION POWDER | ||||||||
101772735 | 10177273 | 2 | SS | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | UNK | UNKNOWN | 21077 | INHALATION POWDER | |||||||||
101772735 | 10177273 | 3 | SS | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 500/50 UG, 1 PUFF(S), BID | 21077 | 1 | DF | INHALATION POWDER | BID | ||||||
101772735 | 10177273 | 4 | SS | FLOVENT | FLUTICASONE PROPIONATE | 1 | Respiratory (inhalation) | 1 PUFF(S), BID | TD4L | 0 | 1 | DF | BID | ||||||
101772735 | 10177273 | 5 | C | FLECAINIDE | FLECAINIDE | 1 | U | 0 | |||||||||||
101772735 | 10177273 | 6 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | U | 0 | |||||||||||
101772735 | 10177273 | 7 | C | ALLOPURINOL. | ALLOPURINOL | 1 | U | 0 | |||||||||||
101772735 | 10177273 | 8 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | U | 0 | |||||||||||
101772735 | 10177273 | 9 | C | LEVETIRACETAM. | LEVETIRACETAM | 1 | U | 0 | |||||||||||
101772735 | 10177273 | 10 | C | DILTIAZEM. | DILTIAZEM | 1 | U | 0 | |||||||||||
101772735 | 10177273 | 11 | C | LASIX | FUROSEMIDE | 1 | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
101772735 | 10177273 | 1 | Scoliosis |
101772735 | 10177273 | 2 | Asthma |
101772735 | 10177273 | 4 | Asthma |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
101772735 | 10177273 | OT |
101772735 | 10177273 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
101772735 | 10177273 | Blood test abnormal | |
101772735 | 10177273 | Cataract operation | |
101772735 | 10177273 | Dyspnoea | |
101772735 | 10177273 | Eye disorder | |
101772735 | 10177273 | Lung disorder | |
101772735 | 10177273 | Malaise | |
101772735 | 10177273 | Product cleaning inadequate | |
101772735 | 10177273 | Pulmonary fibrosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
101772735 | 10177273 | 1 | 20101208 | 0 | ||
101772735 | 10177273 | 2 | 2010 | 0 |